Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity company, regularly receiving stem cell intravenous infusion therapy over the past year.

On August 21, Bloomberg reported that CEX co-founder Arthur Hayes is shifting his investment focus toward the field of human lifespan extension. He has recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok and has joined its board of directors. Over the past year, he has regularly traveled to receive intravenous infusion therapy, stating that "I hope to extend my lifespan as healthily as possible." Although the company name has not been disclosed due to a rebranding, he emphasized: "This is the trend of the future — more and more countries are relaxing regulations on the use of stem cells."